Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Apr 22 2024

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 2 pages · English

Summary by 6ix AI

Zydus Lifesciences Limited has issued a press release announcing the launch of Mirabegron Extended-Release Tablets in the US market. The company received final approval from the United States Food and Drug Administration for this product, which is indicated for treating overactive bladder. Zydus is among the first suppliers to launch this generic version, which is expected to enhance access for patients in the US. The tablets will be manufactured at Zydus's facility in Ahmedabad SEZ, India.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases